Get the tools used by (smart)2 investors.

Net Income to Company for Pfizer Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

PFE: Pfizer Inc

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various...

23.37 EUR
Price
EUR
Fair Value
Upside
22.78 - 29.34
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Pfizer Inc's Net Income to Company:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 20245 B15 B25 B35 B

Performance Summary
  • Pfizer's latest twelve months net income to company is 7.782 billion
  • Pfizer's net income to company for fiscal years ending December 2020 to 2024 averaged 13.189 billion.
  • Pfizer's operated at median net income to company of 7.782 billion from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Pfizer's net income to company peaked in December 2022 at 29.331 billion.
  • Pfizer's net income to company hit its 5-year low in December 2023 of 1.955 billion.
  • Pfizer's net income to company decreased in 2020 (7.527 billion, -47.4%) and 2023 (1.955 billion, -93.3%) and increased in 2021 (19.35 billion, +157.1%), 2022 (29.331 billion, +51.6%), and 2024 (7.782 billion, +298.1%).

How does Pfizer's Net Income to Company benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Pfizer Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Net Income to Company

Hide this widget
ni_company
Slug
number
Datatype
text
Format
current
Default Period
FY, Q, LTM, YTD
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Net Income to Company in the financials category include:

  • NCAV Per Share - A calculation inspired by Benjamin Graham. Net Current Asset Value is calculated as current assets minus total liabilities. NCAV per share expresses this calculation on a per share basis.
  • Unlevered Free Cash Flow - A cash flow measure that represents cash available to all providers of capital, including debt, equity, and hybrid capital. It is used to remove the impact of capital structure on a firm’s value.
  • Tangible Equity - The book value of total equity less intangible assets.
  • Total Capital - Total Capital is a supplemental line item with the following components: Total Preferred Equity, Total Debt, Total Common Equity, and Minority Interest, Total (Incl. Fin. Div).
View Full List

Search for metric or datapoint

Net Income to Company

This item represents the net income available to all stakeholders of the company and is presented as total income or loss before discontinued operatio...

Definition of Net Income to Company

Hide this widget

Pfizer reported net income to company of 7.782 B for the latest twelve months ending December 31, 2024 on its income statement.

The tables below summarizes Pfizer’s Net Income to Company and common size over the last five years:

Fiscal YearNet Income to CompanyRevenue% Revenue
2020-12-317.527 B34.096 B22.1%
2021-12-3119.35 B71.42 B27.1%
2022-12-3129.331 B94.487 B31.0%
2023-12-311.955 B53.944 B3.6%
2024-12-317.782 B61.419 B12.7%

The tables below summarizes Pfizer’s Net Income to Company and common size over the last four quarters:

Quarter EndingNet Income to CompanyRevenue% Revenue
2024-03-312.894 B13.787 B21.0%
2024-06-3044.808 M12.4 B0.4%
2024-09-294.006 B15.853 B25.3%
2024-12-31403.5 M17.148 B2.4%

Click the link below to download a spreadsheet with an example Net Income to Company calculation for Pfizer Inc below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-317.8 M82.211 M482.2 M1.239 B04008001,200

The chart above depicts the distribution of net income to company for companies operating in the Healthcare sector in the Developed economic region. Over 2,500 companies were considered in this analysis, and 2,406 had meaningful values. The average net income to company of companies in the sector is -91.939 K with a standard deviation of 140.3 M.

Pfizer Inc's Net Income to Company of 7.782 B is significantly outside the interquartile range and is excluded from the distribution. The following table provides additional summary stats:

Net Income to Company In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,506
Included Constituents2,406
Min-343.7 M
Max1.229 B
Median-4.808 M
Mean-91.939 K
Standard Deviation140.3 M

You can find companies with similar net income to company using this stock screener.

All rights reserved. Terms Of Use